Alexandria Real Estate Equities, Inc. (ARE): A Bull Case Theory
Aerial city skyline highlighting a large modern office building owned by the REIT.
Alexandria Real Estate Equities (ARE) is a specialized REIT that develops and leases high-tech life science and biotech campuses in top innovation clusters like Boston, San Diego, and the San Francisco Bay Area. Its tenants include leading names such as Eli Lilly, Moderna, and Google, who sign long-term leases—offering predictable, high-quality rental income. As of the latest trading, ARE is priced at $72, yielding a 7.2% dividend, the highest in over a decade. The dividend is well-supported by Funds From Operations (FFO), which totaled $8.11 per share in 2024, with guidance of $9.26 per share for 2025.
Alexandria's payout ratio remains healthy, and its dividend has increased for 15 consecutive years at a 5.2% CAGR. The REIT boasts a strong balance sheet, with a 0.6x debt/equity ratio, a 12.7-year average debt maturity at a low 3.86% interest rate, and an investment-grade credit rating. The company's capital allocation strategy centers around its Megacampus model—large-scale, amenity-rich campuses near top research universities. To fund this strategy, ARE has actively recycled capital by selling non-core assets and repurchasing shares, minimizing shareholder dilution. While its occupancy dipped to 91.7% in Q1 due to expected tenant transitions, fundamentals remain intact.
However, its tight concentration in the U.S. life sciences sector introduces risk, especially as federal research funding faces political scrutiny. Valuation appears attractive, with a forward P/FFO of just 7.8x versus a historical average of 14x. While ARE's fundamentals are strong, investors must weigh its upside against its exposure to the volatile biotech ecosystem.
Previously, we covered a on JBG SMITH Properties (JBGS) by Jake LaMotta in September 2024, which highlighted strong multifamily performance, office asset pruning, and buybacks. The stock has appreciated approximately 9.05% since then as multifamily trends played out positively. The thesis still stands as low D.C. supply supports NOI growth. TJ Terwilliger shares a similar view on ARE, emphasizing biotech campus focus.
Alexandria Real Estate Equities, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held ARE at the end of the first quarter which was 36 in the previous quarter. While we acknowledge the potential of ARE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Moderna, Inc. (MRNA)'s 'Got The Double Whammy,' Says Jim Cramer
We recently published . Moderna, Inc. (NASDAQ:MRNA) is one of the stocks Jim Cramer recently discussed. Moderna, Inc. (NASDAQ:MRNA) has been one of the most ill-fated stocks in 2025. The shares have lost 38% year-to-date as the firm has struggled to diversify away from its mRNA vaccines amidst slipping demand for the products. For instance, Moderna, Inc. (NASDAQ:MRNA)'s full-year revenue guidance of $1.5 billion to $2.2 billion given during its second quarter earnings was lower than the earlier guidance of $1.5 billion to $2.2.5 billion. The reason behind the trimmed guidance was deferred revenue from its COVID vaccines. Cramer discussed Moderna, Inc. (NASDAQ:MRNA) in the context of RFK Jr: 'Hey that's got the double whammy. It's vaccine, got a guy at HHS doesn't like it, they never did anything with the other one.' Copyright: nexusplexus / 123RF Stock Photo The CNBC TV host discussed Moderna, Inc. (NASDAQ:MRNA) in May. Here is what he said: 'There's gotta be some value in Moderna. There just has to be, but I've been against this stock for so long. I first discovered it at 18. Maybe that should be the price target.' While we acknowledge the potential of MRNA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 hours ago
- Yahoo
Charter Hall Long WALE REIT Full Year 2025 Earnings: EPS Misses Expectations
Explore Charter Hall Long WALE REIT's Fair Values from the Community and select yours Charter Hall Long WALE REIT (ASX:CLW) Full Year 2025 Results Key Financial Results Revenue: AU$346.9m (up 141% from FY 2024). Net income: AU$118.3m (up from AU$510.9m loss in FY 2024). Profit margin: 34% (up from net loss in FY 2024). EPS: AU$0.17 (up from AU$0.71 loss in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Charter Hall Long WALE REIT EPS Misses Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 30%. In the last 12 months, the only revenue segment was REIT - Commercial contributing AU$346.9m. The most substantial expense, totaling AU$166.8m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how CLW's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 3.5% decline forecast for the REITs industry in Australia. Performance of the Australian REITs industry. The company's shares are up 6.8% from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 3 warning signs for Charter Hall Long WALE REIT (of which 2 can't be ignored!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
July brings slower sales pace and reduced buyer activity to Northeast Florida housing market
In July, the Northeast Florida housing market showed signs of cooling, with a decrease in buyer activity and a more deliberate pace of sales. The median sales price for single-family homes in the region rose slightly to $394,000, while the Home Affordability Index remained at 66. Closed sales for single-family homes totaled 1,849 transactions, marking a 9.4% decrease from June. Pending sales also saw a significant drop of 28.9%. 'Buyers who were unsuccessful in buying a home during the strong seller's market of the COVID years have been begging for a market shift towards these exact conditions,' said NEFAR President, Mario Gonzalez. The Northeast Florida housing market is experiencing a shift towards a more balanced environment, with properties spending longer on the market compared to earlier in the year. This change is giving buyers more choices and room to negotiate. In July, there were 2,613 new listings, which represented a 4.3% drop from the previous month. However, the active inventory of properties increased by 10.7% from the previous year, with 8,882 properties available. This rise in inventory is a positive change for buyers, as they have more options to choose from. The median number of days on the market for properties was 43, indicating a slower pace of sales. 'These conditions are much more representative of a balanced market, and experienced realtors can help buyers and sellers navigate much more successfully than trying to go it alone in these waters,' added Gonzalez. >>> STREAM ACTION NEWS JAX LIVE <<< [DOWNLOAD: Free Action News Jax app for alerts as news breaks] [SIGN UP: Action News Jax Daily Headlines Newsletter] Click here to download the free Action News Jax news and weather apps, click here to download the Action News Jax Now app for your smart TV and click here to stream Action News Jax live. Solve the daily Crossword
